Skip to main content
. Author manuscript; available in PMC: 2019 Sep 23.
Published in final edited form as: Am J Med. 2014 Dec 30;128(7):715–721. doi: 10.1016/j.amjmed.2014.11.036

Table 3.

Association between a new discharge prescription for beta-blocker and 4-year post-discharge outcomes in a propensity-matched cohort of Medicare beneficiaries hospitalized for heart failure

(events)
Outcomes New discharge prescription for b-blocker
Absolute risk diff.* Hazard ratio (95 confidence interval)
No (n=380) %,N Yes (n=380) %,N
All-cause hospital readmission 83 (315) 81 (309) −2 0.89 (0.76–1.04)
Heart failure readmission 49 (186) 49 (187)  0 0.92 (0.75–1.13)
All-cause mortality 60 (226) 53 (202) −7 0.81 (0.67–0.98)
All-cause mortality or all-cause readmission 94 (357) 89 (339) −5 0.86 (0.74–0.97)
*

Absolute risk differences(%) were calculated by subtracting percent events in patients receiving no beta-blocker from those receiving those drugs

The hazard ratios compared patients receiving beta-blocker versus those not receiving beta-blocker. These hazard ratios were calculated by treating patients without events during the first 30 days as censored